Vericel Corporation VCEL
59.03 USD +0.64 (+1.10%)
At closeNov 10, 2026, 4:20 PM EST
59.03 0.00 0.00%
After hours · Nov 10, 4:20 PM ET
57.83 Day range 59.72
28.95 52-week range 59.72
- YTD
- +63.93%
- 1 year
- +51.40%
News
zacks.com Earnings Estimates Moving Higher for Vericel (VCEL): Time to Buy? Vericel Corporation (VCEL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
benzinga.com Stephens & Co. Maintains Overweight on Vericel, Raises Price Target to $68 Stephens & Co. analyst Mason Carrico maintains Vericel (NASDAQ:VCEL) with a Overweight and raises the price target from $55 to $68.
benzinga.com Truist Securities Maintains Buy on Vericel, Raises Price Target to $65 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $52 to $65.
marketbeat.com Vericel Q3 Earnings Call Highlights Vericel NASDAQ: VCEL raised its full-year revenue and profitability outlook after third-quarter sales rose 26%, led by growth in its MACI cartilage repair product and a record quarter for its burn…
seekingalpha.com Vericel Corporation (VCEL) Q3 2026 Earnings Call Transcript Vericel Corporation ( VCEL ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST Company Participants Eric Burns - Vice President of Finance & Investor Relations Dominick C. Colangelo - CEO, President…
benzinga.com HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $75 HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $72 to $75.
defenseworld.net Vericel (NASDAQ:VCEL) Hits New 12-Month High on Strong Earnings Vericel Corporation (NASDAQ: VCEL - Get Free Report)'s stock price hit a new 52-week high during trading on Thursday after the company announced better than expected quarterly earnings. The company…
zacks.com Vericel Corporation (VCEL) Beats Q3 Earnings and Revenue Estimates Vericel Corporation (VCEL) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.1 per share a year ago.
benzinga.com Motorola Solutions, Sezzle, Unity Software, Toyota Motor And Other Big Stocks Moving Higher On Thursday U.S. stocks were mixed as Nasdaq fell over 3%, while Motorola Solutions and other companies surged on strong earnings and raised guidance.
benzinga.com Vericel Q3 2026 Earnings Call Transcript Vericel (NASDAQ:VCEL) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…- benzinga.com Vericel Q3 EPS $0.27 Beats $0.06 Estimate, Sales $85.371M Beat $77.948M Estimate Vericel (NASDAQ:VCEL) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.06 by 350 percent. This is a 170 percent increase over earnings of $0.10 per share…
- benzinga.com Vericel Raises FY2026 Sales Guidance from $330.000M-$340.000M to $344.000M-$346.000M vs $336.224M Est Vericel (NASDAQ:VCEL) raises FY2026 sales outlook from $330.000 million-$340.000 million to $344.000 million-$346.000 million vs $336.224 million estimate.
globenewswire.com Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance Total Revenue Growth of 26% to $85.4 Million Net Income Increased 179% to $14.2 Million Adjusted EBITDA Margin of 30% Raised Full-Year Revenue Guidance to $344 to $346 Million and Adjusted EBITDA…
defenseworld.net Alkermes (NASDAQ:ALKS) vs. Vericel (NASDAQ:VCEL) Head to Head Contrast Vericel (NASDAQ: VCEL - Get Free Report) and Alkermes (NASDAQ: ALKS - Get Free Report) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based…
defenseworld.net Comparing Vericel (NASDAQ:VCEL) and Zymeworks (NASDAQ:ZYME) Zymeworks (NASDAQ: ZYME - Get Free Report) and Vericel (NASDAQ: VCEL - Get Free Report) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based…
globenewswire.com Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026 BURLINGTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the…
benzinga.com Truist Securities Maintains Buy on Vericel, Lowers Price Target to $52 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $58 to $52.
seekingalpha.com Vericel Corporation (VCEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Vericel Corporation (VCEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
seekingalpha.com Vericel: MACI And Regenerative Knee Cartilage Vericel's MACI already has an established commercial base, which I think gives them an easier path for future growth. MACI's arthroscopic delivery could also help it expand among surgeons. That's why…
globenewswire.com Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026 BURLINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the…
defenseworld.net Canada Pension Plan Investment Board Takes Position in Vericel Corporation $VCEL Canada Pension Plan Investment Board purchased a new position in Vericel Corporation (NASDAQ: VCEL) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund…
defenseworld.net Vericel Corporation $VCEL Shares Purchased by Bank of America Corp DE Bank of America Corp DE boosted its holdings in Vericel Corporation (NASDAQ: VCEL) by 19.7% during the undefined quarter, according to its most recent disclosure with the SEC. The firm owned…
benzinga.com TD Cowen Maintains Buy on Vericel, Raises Price Target to $58 TD Cowen analyst Joshua Jennings maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $55 to $58.
benzinga.com Truist Securities Reiterates Buy on Vericel, Raises Price Target to $58 Truist Securities analyst Richard Newitter reiterates Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $54 to $58.- benzinga.com HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $72 HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $70 to $72.
marketbeat.com Vericel Q2 Earnings Call Highlights Vericel NASDAQ: VCEL reported record second-quarter revenue and raised its full-year outlook, citing continued growth in its MACI cartilage repair franchise and Burn Care business, along with…
seekingalpha.com Vericel Corporation (VCEL) Q2 2026 Earnings Call Transcript Vericel Corporation (VCEL) Q2 2026 Earnings Call Transcript
zacks.com Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates Vericel Corporation (VCEL) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to a loss of $0.01 per share a year…- benzinga.com Vericel Q2 EPS $0.04 Beats $(0.03) Estimate, Sales $77.457M Beat $72.689M Estimate Vericel (NASDAQ:VCEL) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.03) by 233.33 percent. This is a 500 percent increase over losses of $(0.01) per…
benzinga.com Vericel Raises FY2026 Sales Guidance from $326.000M-$336.000M to $330.000M-$340.000M vs $332.199M Est Vericel (NASDAQ:VCEL) raises FY2026 sales outlook from $326.000 million-$336.000 million to $330.000 million-$340.000 million vs $332.199 million estimate.
globenewswire.com Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program Total Revenue Increased 22% to $77.5 Million, with MACI Revenue Growth of 23% Net Income of $2.2 Million and Free Cash Flow of $14.3 Million Full-Year 2026 Revenue Guidance Raised to $330 to $340…- benzinga.com HC Wainwright & Co. Reiterates Buy on Vericel, Maintains $70 Price Target HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vericel (NASDAQ:VCEL) with a Buy and maintains $70 price target.
defenseworld.net Vericel Corporation $VCEL Shares Sold by Allspring Global Investments Holdings LLC Allspring Global Investments Holdings LLC trimmed its position in Vericel Corporation (NASDAQ: VCEL) by 3.1% during the first quarter, according to its most recent filing with the Securities and…
benzinga.com Truist Securities Maintains Buy on Vericel, Raises Price Target to $54 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $42 to $54.
globenewswire.com Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026 BURLINGTON, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the…- benzinga.com HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $70 HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $64 to $70.
- benzinga.com Vericel Raises FY2026 Sales Guidance from $316.000M-$326.000M to $326.000M-$336.000M vs $323.377M Est Vericel (NASDAQ:VCEL) raises FY2026 sales outlook from $316.000 million-$326.000 million to $326.000 million-$336.000 million vs $323.377 million estimate.
- benzinga.com Vericel Q1 EPS $(0.12) Beats $(0.15) Estimate, Sales $68.425M Beat $63.638M Estimate Vericel (NASDAQ:VCEL) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 47.83 percent increase over losses of $(0.23) per…
- benzinga.com Truist Securities Maintains Buy on Vericel, Lowers Price Target to $42 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $48 to $42.
benzinga.com Vericel Corp. Awarded $196.8M HHS BARDA Contract For NonSurgical Debridement, Research And Development In Biotechnology (Except Nanobiotechnology) https://sam.gov/opp/f339ca12b7e047cdac559fe926d1a190/view- benzinga.com HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $64 HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $60 to $64.
- benzinga.com Vericel Sees FY2026 Sales $316.000M-$326.000M vs $325.310M Est 2026 Financial GuidanceTotal revenue of $316 to $326 millionMACI revenue of $280 to $286 millionGross margin of approximately 75%Adjusted EBITDA margin of approximately 27%
- benzinga.com Vericel Q4 EPS $0.45 Beats $0.39 Estimate, Sales $92.918M Beat $91.122M Estimate Vericel (NASDAQ:VCEL) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.39 by 15.38 percent. This is a 18.42 percent increase over earnings of $0.38 per…
benzinga.com Earnings Breakdown: Vericel Q4 
benzinga.com Earnings Scheduled For February 26, 2026 
benzinga.com Why Is Vericel Stock Gaining Tuesday? Vericel Corporation (NASDAQ: VCEL) stock rose on Tuesday after announcing preliminary financial results for 2025.- benzinga.com Truist Securities Maintains Buy on Vericel, Lowers Price Target to $45 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $50 to $45.
- benzinga.com Truist Securities Reiterates Buy on Vericel, Raises Price Target to $50 Truist Securities analyst Richard Newitter reiterates Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $41 to $50.
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com Truist Securities Maintains Buy on Vericel, Lowers Price Target to $41 Truist Securities analyst Richard Newitter maintains Vericel (NASDAQ:VCEL) with a Buy and lowers the price target from $46 to $41.